Clinical Trial Update: Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing changes in organ-specific amyloid load using repeat PET/CT imaging with the tracer Amyloid 124I-AT-01 in patients with systemic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• Amyloid 124I-AT-01

Snippet

Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Systemic Amyloidosis | Phase 2 | Status: COMPLETED